Empirical Evidence and Psychotherapy: A Growing Scientific Base
2001; American Psychiatric Association; Volume: 158; Issue: 1 Linguagem: Inglês
10.1176/appi.ajp.158.1.1
ISSN1535-7228
Autores Tópico(s)Mental Health Research Topics
ResumoBack to table of contents Next article EditorialFull AccessEmpirical Evidence and Psychotherapy: A Growing Scientific BaseGLEN O. GABBARD, M.D.GLEN O. GABBARD, M.D.Published Online:1 Jan 2001https://doi.org/10.1176/appi.ajp.158.1.1AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail We live in a society enamored of technology. Health care is delivered in the context of that society, of course, and reimbursement patterns for treatment reflect the bias towards "high-tech" medicine. It is not uncommon for insurance policies to pay in six figures for organ transplants but offer only nickels and dimes for psychotherapy. The idea that something therapeutic may occur when someone talks to a trained professional has always been controversial. In some quarters, psychotherapy is viewed as being akin to hand-holding.To be sure, practitioners of psychotherapy have been slow to use rigorous empirical methods to demonstrate the usefulness of what they do. At long last, however, research data have been accumulating that suggest psychotherapy produces lasting improvements and even changes brain functioning (1–3). Because the mind is inextricably connected to the brain, these findings should not come as a surprise. Indeed, it is a remnant of persistent Cartesian thinking that has led many skeptics to think that psychotherapy may be nothing more than balm for the "worried well." A 1999 report by Bateman and Fonagy (4) helped to put that view to rest by pointing out that even with seriously disturbed patients, such as those suffering from borderline personality disorder, psychoanalytically oriented psychotherapy in the context of a partial hospital program could effect far-reaching changes in suicidality, acts of self-harm, the need for hospitalization, and a host of psychiatric symptoms, including depression and anxiety.In this issue of the Journal the same investigators report on their sample of 44 patients with borderline personality disorder after 18 months of follow-up. They demonstrate that the significant clinical improvement resulting from the original 18-month psychoanalytically oriented partial hospital program was maintained at follow-up a year and a half later. While this finding is encouraging, the news is even better. They also found that the patients who received the treatment continued to improve in measures of symptom distress, major clinical difficulties, need for hospitalization, and self-harm. The psychotherapy literature has suggested that psychoanalytic/psychodynamic treatments might be associated with continued improvement after termination of the therapy (5), and the Bateman and Fonagy study adds more evidence to that growing impression. However, even though the partial hospital program had ended, the patients who had been randomly assigned to the partial hospital group continued in psychoanalytic group therapy twice a week, so the impact of that treatment must be considered in terms of assessing the continued improvement.It is noteworthy that while the investigators employed a rigorous experimental design, including random assignment to either the experimental group or the control group, they stressed that their study was an effectiveness trial rather than an efficacy trial. In recent years a backlash has developed against tightly controlled efficacy studies of psychotherapy in academic settings (6–10). Criticisms of this approach have included the fact that 80% to 90% of subjects are excluded, patients who respond to advertising may be different from patients seen in naturalistic settings, patients with complicated comorbidity are not included, and generalizability from the artificial research setting to the "real world" may be limited. To address these concerns, NIMH has specifically called for more effectiveness research (11). This contribution by Bateman and Fonagy is a model of effectiveness research, as ordinary clinical referrals were the subjects of the study, a bare minimum of exclusion criteria were used, and the psychotherapy was conducted in a naturalistic setting.Psychotherapy is often thought to be prohibitively expensive. Insurance companies have had a long history of discriminating against the use of psychotherapy as a treatment for fear that it will "break the bank." Although strict cost-effectiveness measures were not employed in the research design, the study by Bateman and Fonagy provides provocative data suggesting that in some cases we may actually save money by providing effective psychotherapy. If they are untreated, patients with borderline personality disorder often utilize expensive health care resources, such as inpatient treatment, intensive care, and emergency room services. The patients participating in the study intervention had fewer episodes of self-harm and fewer suicide attempts. They also dramatically decreased their use of inpatient treatment, while the control group used more of all types of services than the treatment group, supporting the view that psychotherapy may be highly cost-effective in treating patients with borderline personality disorder (12). If cost-effectiveness measures were systematically incorporated into future psychotherapy studies, the field might reach a point where it would be possible to identify which subgroups of patients warrant the investment of time, energy, and money associated with extended psychotherapy.A second report in this issue of the Journal also makes admirable use of a naturalistic setting to study a complex aspect of the patient-provider relationship in the treatment of diabetes. Ciechanowski et al. used an ingeniously creative approach to examine the nemesis of both medical and psychiatric practice—noncompliance. It has long been known that lack of adherence to diabetic self-management regimens is linked to serious complications of diabetes, including peripheral vascular disease, renal involvement, retinopathy, and neuropathy. The investigators applied adult attachment theory in an attempt to better understand the anatomy of this noncompliance. They found that patients with a dismissing attachment style had significantly higher levels of glycosylated hemoglobin. In addition, among patients with a dismissing attachment style, those who perceived that they had poor communication with their health care provider had higher levels compared to those who felt the quality of communication was good.Attachment theory, which is finally getting the attention it deserves in our field, is based on the seminal work of John Bowlby, who observed that internal working models are developed in every individual based on early experiences with parents and/or caregivers. These models are transposed onto adult relationships and profoundly affect how one relates to others throughout life (the basis of transference in psychoanalytic psychotherapy). Adults who have a dismissing attachment style generally have experienced caregivers or parents as consistently emotionally unresponsive. They become compulsively self-reliant as a result and try to avoid the kind of collaborative relationship necessary for treatment.This contribution underscores the point that psychotherapeutic principles are essential in all provider-patient relationships. Krupnick et al. (13) demonstrated that in depressed patients, the therapeutic alliance is just as important in pharmacotherapy as it is in psychotherapy. Transference-based perceptions of the provider based on the internalized working models from early experience may impair the capacity of a patient to collaborate with a provider and participate in the therapeutic alliance. By making a special effort to reach such patients through sensitive and empathic communication, health care providers may help improve treatment adherence.Ciechanowski et al. have opened the door to a fertile field for research. They are currently collecting data on the attachment style of treaters as well as patients. Such research may teach us sophisticated methods that allow us to assign patients with adherence problems to treaters who have a specific complementary attachment style. This research holds out the possibility of shedding light on the elusive construct of "therapist-patient match."Finally, I have long thought that in training psychiatrists, we make too much of a distinction between psychotherapy and pharmacotherapy. The doctor-patient relationship is inherently psychotherapeutic. Careful attention to concepts such as therapeutic alliance, doctor-patient collaboration, transference, and countertransference apply across the board in all of our interactions with patients. Even when we treat the brain with somatic treatments, we cannot bypass the mind.Address reprint requests to Dr. Gabbard, The Menninger Clinic, P. O. Box 829, Topeka, KS 66601-0829; [email protected] (e-mail).References1. Gabbard GO: A neurobiologically informed perspective on psychotherapy. Br J Psychiatry 2000; 177:117–122Crossref, Medline, Google Scholar2. Baxter LR, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazrakai A, Selin CE, Ferng HK, Munford P, Phelps M: Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49:681–689Crossref, Medline, Google Scholar3. Viinamäki H, Kuikka J, Tiihonen J, Lehtonen J: Change in monoamine transporter density related to clinical recovery: a case-control study. Nord J Psychiatry 1998; 52:39–44Crossref, Google Scholar4. Bateman A, Fonagy P: Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 1999; 156:1563–1569Google Scholar5. Anderson EM, Lambert MJ: Short-term dynamically oriented psychotherapy: a review and meta-analysis. Clin Psychol Rev 1995; 15:503–514Crossref, Google Scholar6. Bohart AC, O'Hara M, Leitner LM: Empirically violated treatments: disenfranchisement of humanistic and other psychotherapies. Psychother Res 1998; 8:141–157Google Scholar7. Elliot R: Editor's introduction: a guide to the empirically supported treatments controversy. Psychother Res 1998; 8:115–125Crossref, Google Scholar8. Gunderson JG, Gabbard GO: Making the case for psychoanalytic therapy in the current psychiatric environment. J Am Psychoanal Assoc 1999; 47:679–704Medline, Google Scholar9. Henry WP: Science, politics, and the politics of science: the use and misuse of empirically validated treatment research. Psychother Res 1998; 8:126–140Crossref, Google Scholar10. Seligman MEP: The effectiveness of psychotherapy: the Consumer Reports study. Am Psychol 1995; 50:965–974Crossref, Medline, Google Scholar11. Markowitz J, Street L: NIMH propels psychotherapy research on new course. Psychiatr News, Oct 15, 1999, p 20Google Scholar12. Gabbard GO, Lazar SG, Hornberger J, Spiegel D: The economic impact of psychotherapy: a review. Am J Psychiatry 1997; 154:147–155Link, Google Scholar13. Krupnick JL, Sotsky SM, Simmens S, Moyer J, Elkin I, Watkins J, Pilkonis PA: The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol 1996; 64:532–539Crossref, Medline, Google Scholar FiguresReferencesCited byDetailsCited ByPrescribing of antipsychotics among people with recorded personality disorder in primary care: a retrospective nationwide cohort study using The Health Improvement Network primary care database9 March 2022 | BMJ Open, Vol. 12, No. 3Therapists' emotional state after sessions in which suicidality is addressed: need for improved management of suicidal tendencies in patients with borderline personality pathology23 November 2021 | BMC Psychiatry, Vol. 21, No. 1DBT-skills system for cognitively challenged individuals with self-harm: a Swedish pilot study1 September 2021 | International Journal of Developmental Disabilities, Vol. 23Self-Contempt, the Working Alliance and Outcome in Treatments for Borderline Personality Disorder: An Exploratory Study30 November 2020 | Psychotherapy Research, Vol. 31, No. 6Mechanisms of change in dialectical behaviour therapy and cognitive behaviour therapy for borderline personality disorder: a critical review of the literature8 May 2017 | Journal of Mental Health, Vol. 29, No. 1Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough?6 November 2019 | Expert Opinion on Pharmacotherapy, Vol. 21, No. 1Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial24 June 2019 | BMC Psychiatry, Vol. 19, No. 1Augmenting Psychiatric Risk Management: Practical Applications of Transference- Focused Psychotherapy (TFP) PrinciplesPsychodynamic Psychiatry, Vol. 47, No. 4Treatment of Borderline Personality Disorder: Is Supply Adequate to Meet Public Health Needs?Evan A. Iliakis, B.A., Anne K. I. Sonley, M.D., J.D., Gabrielle S. Ilagan, B.A., Lois W. Choi-Kain, M.D., M.Ed.29 May 2019 | Psychiatric Services, Vol. 70, No. 9The experiences of people with borderline personality disorder admitted to acute psychiatric inpatient wards: a meta-synthesis7 July 2017 | Journal of Mental Health, Vol. 28, No. 4General psychiatric management: An evidence-based treatment for borderline personality disorder in the college setting10 August 2018 | Journal of College Student Psychotherapy, Vol. 33, No. 2International Journal of Psychiatry in Clinical Practice, Vol. 23, No. 3Real-World Effectiveness of Clozapine for Borderline Personality Disorder: Results From a 2-Year Mirror-Image StudyJournal of Personality Disorders, Vol. 32, No. 6Current Opinion in Psychiatry, Vol. 31, No. 1Psychodynamic Psychiatry, Vol. 46, No. 2Revista Brasileira de Psiquiatria, Vol. 40, No. 3Pharmacotherapy of personality disorders: what we know and what we have to search forFuture Neurology, Vol. 12, No. 4Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial24 July 2017 | CNS Drugs, Vol. 31, No. 9Qualitative Analysis of Resources and Barriers Related to Treatment of Borderline Personality Disorder in the United StatesMatthew C. Lohman, Ph.D., M.H.S., Karen L. Whiteman, Ph.D., Frank E. Yeomans, M.D., Ph.D., Sheila A. Cherico, L.C.S.W., Winifred R. Christ, D.S.W., L.C.S.W.3 October 2016 | Psychiatric Services, Vol. 68, No. 2Farmacotherapie persoonlijkheidsstoornissen23 June 2017CNS Drugs, Vol. 31, No. 5British Journal of Guidance & Counselling, Vol. 45, No. 3International Journal of Psychiatry in Clinical Practice, Vol. 21, No. 1Psychotherapy, Parity, and Ethical Utilization ManagementJournal of Psychiatric Practice, Vol. 23, No. 1Evaluation of changes in prescription medication use after a residential treatment programme for borderline personality disorder10 July 2016 | Australasian Psychiatry, Vol. 24, No. 6Therapist Adherence to Good Psychiatric Practice in a Short-Term Treatment for Borderline Personality DisorderJournal of Nervous & Mental Disease, Vol. 204, No. 7: en17 August 2016Journal of Contemporary Psychotherapy, Vol. 46, No. 1Middle East Current Psychiatry, Vol. 23, No. 2The Efficacy of Pharmacotherapy for Borderline Personality Disorder: A Review of the Available Randomized Controlled TrialsPsychiatric Annals, Vol. 45, No. 8Current Psychiatry Reports, Vol. 17, No. 1Trials, Vol. 16, No. 1Borderline Personality Disorder and Emotion Dysregulation, Vol. 2, No. 1Psychodynamic Psychiatry, Vol. 43, No. 2Journal of Personality Disorders, Vol. 29, No. 5International Journal of Psychiatry in Clinical Practice, Vol. 19, No. 1Studies of Personality Disorders: Past, Present, and Future in Recognition of ISSPD's 25th AnniversaryJournal of Personality Disorders, Vol. 28, No. 5The Validity of the MSI-BPD Among Inpatient Adolescents23 January 2013 | Assessment, Vol. 21, No. 2Meta-Analysis and Systematic Review Assessing the Efficacy of Dialectical Behavior Therapy (DBT)19 September 2013 | Research on Social Work Practice, Vol. 24, No. 2Nordic Psychology, Vol. 66, No. 4Journal of Personality Disorders, Vol. 28, No. 4Managing Borderline Personality Disorder on General Psychiatric UnitsPsychodynamic Psychiatry, Vol. 41, No. 4Changes in Treated Incidence of Borderline Personality Disorder in Denmark: 1970–20091 September 2013 | The Canadian Journal of Psychiatry, Vol. 58, No. 9The concept of borderline personality22 March 2013 | Australian & New Zealand Journal of Psychiatry, Vol. 47, No. 8Psychopharmacologic treatment of borderline personality disorder1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 15, No. 2Behavioral Medicine, Vol. 39, No. 2Psychotherapy Research, Vol. 23, No. 6Person-Centered & Experiential Psychotherapies, Vol. 12, No. 2International Journal of Forensic Mental Health, Vol. 12, No. 3Journal of College Student Psychotherapy, Vol. 27, No. 1Current Opinion in Psychiatry, Vol. 26, No. 1Expert Review of Pharmacoeconomics & Outcomes Research, Vol. 13, No. 1Use of Dialectical Behavior Therapy in Inpatient Treatment of Borderline Personality Disorder: A Systematic ReviewJill Myerow Bloom, M.A., Eva N. Woodward, M.A., Teresa Susmaras, M.A., and David W. Pantalone, Ph.D.1 September 2012 | Psychiatric Services, Vol. 63, No. 9The Difficult PatientObstetrical & Gynecological Survey, Vol. 67, No. 8Frequency of Borderline Personality Disorder Among Psychiatric Outpatients in Shanghai11 April 2012 | Journal of Personality DisordersJournal of Personality Disorders, Vol. 26, No. 3Clinical Practice, Vol. 9, No. 4Supervised team management, with or without structured psychotherapy, in heavy users of a mental health service with borderline personality disorder: a two-year follow-up preliminary randomized study21 November 2011 | BMC Psychiatry, Vol. 11, No. 1Barriers to Implementing the Clinical Guideline on Borderline Personality Disorder in the NetherlandsMarleen L. M. Hermens, Ph.D., Peter T. van Splunteren, M.Sc., Annemiek van den Bosch, M.Sc., and Roel Verheul, Ph.D.13 January 2015 | Psychiatric Services, Vol. 62, No. 11Differential Effectiveness of Antipsychotics in Borderline Personality DisorderJournal of Clinical Psychopharmacology, Vol. 31, No. 4State of the Art in the Pharmacologic Treatment of Borderline Personality Disorder8 December 2010 | Current Psychiatry Reports, Vol. 13, No. 1The International Journal of Neuropsychopharmacology, Vol. 14, No. 09New England Journal of Medicine, Vol. 364, No. 21Journal of Aggression, Maltreatment & Trauma, Vol. 20, No. 6Neuropsychiatry, Vol. 1, No. 3International Review of Psychiatry, Vol. 23, No. 3Borderline personality disorder: current drug treatments and future prospects24 May 2010 | Therapeutic Advances in Chronic Disease, Vol. 1, No. 2Adaptation of Interpersonal Psychotherapy to Borderline Personality Disorder: A Comparison of Combined Therapy and Single Pharmacotherapy1 February 2010 | The Canadian Journal of Psychiatry, Vol. 55, No. 2Psychopharmakotherapie einer ambulanten und stationären Inanspruchnahmepopulation adoleszenter Patienten mit Borderline-PersönlichkeitsstörungZeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, Vol. 38, No. 1Use of psychotropics in special patient groups8 March 2013Personality Trait Dimensions and the Pharmacological Treatment of Borderline Personality DisorderJournal of Clinical Psychopharmacology, Vol. 29, No. 5Borderline Personality or Complex Posttraumatic Stress Disorder? An Update on the ControversyHarvard Review of Psychiatry, Vol. 17, No. 5The Treatment of Borderline Personality Disorder: Implications of Research on Diagnosis, Etiology, and OutcomeAnnual Review of Clinical Psychology, Vol. 5, No. 1Demonstrating Adherence to Guidelines for the Treatment of Patients with Borderline Personality Disorder1 March 2009 | The Canadian Journal of Psychiatry, Vol. 54, No. 3Issues in Mental Health Nursing, Vol. 30, No. 10American Journal of Psychiatric Rehabilitation, Vol. 12, No. 3Mental Health and Substance Use, Vol. 2, No. 2Journal of Psychiatric Practice, Vol. 15, No. 6Targeted Clinical Education for Staff Attitudes Towards Deliberate Self-Harm in Borderline Personality Disorder: Randomized Controlled Trial1 January 2008 | Australian & New Zealand Journal of Psychiatry, Vol. 42, No. 11Professional Attitudes Towards Deliberate Self-Harm in Patients With Borderline Personality Disorder1 January 2008 | Australian & New Zealand Journal of Psychiatry, Vol. 42, No. 7Chronic Suicidality in a Physician: An Alliance Yet to Become TherapeuticHarvard Review of Psychiatry, Vol. 16, No. 3An Evidence-Based Approach to Managing Suicidal Behavior in Patients with BPDSocial Work in Mental Health, Vol. 6, No. 1-2Personality and Mental Health, Vol. 2, No. 1Psychoanalytic Psychotherapy, Vol. 22, No. 4Nordic Journal of Psychiatry, Vol. 62, No. 6Archives of Suicide Research, Vol. 12, No. 1Journal of Clinical Psychopharmacology, Vol. 28, No. 2Acta Neuropsychiatrica, Vol. 20, No. 1Social Work in Mental Health, Vol. 6, No. 1-2A National Survey of Canadian Psychiatry Residents' Perceptions of Psychotherapy Training1 November 2007 | The Canadian Journal of Psychiatry, Vol. 52, No. 11Combined Therapy of Major Depression with Concomitant Borderline Personality Disorder: Comparison of Interpersonal and Cognitive Psychotherapy1 November 2007 | The Canadian Journal of Psychiatry, Vol. 52, No. 11Intermittent-Continuous Eclectic Therapy: A Group Approach for Borderline Personality DisorderJournal of Psychiatric Practice, Vol. 13, No. 4Cutting29 November 2016 | AAOHN Journal, Vol. 55, No. 4New frontiers in the role of hospitalization for patients with personality disorders18 April 2007 | Current Psychiatry Reports, Vol. 9, No. 1Mentalization-Based Treatment voor patiënten met een borderline persoonlijkheidsstoornisMedicamenteuze behandelingDer Nervenarzt, Vol. 78, No. 9International Journal of Clinical and Experimental Hypnosis, Vol. 55, No. 2International Review of Psychiatry, Vol. 19, No. 1Journal of Mental Health, Vol. 16, No. 1Psychotherapy Research, Vol. 17, No. 3Eating Disorders, Vol. 15, No. 4The World Journal of Biological Psychiatry, Vol. 8, No. 4International Journal of Mental Health Nursing, Vol. 16, No. 1Behaviour Change, Vol. 24, No. 1EMDR in the Treatment of Borderline Personality Disorder24 July 2016 | Clinical Case Studies, Vol. 5, No. 5Borderline Personality Disorder, Stigma, and Treatment ImplicationsHarvard Review of Psychiatry, Vol. 14, No. 5Combined Treatment of Major Depression in Patients with Borderline Personality Disorder: A Comparison with Pharmacotherapy1 June 2006 | The Canadian Journal of Psychiatry, Vol. 51, No. 7Neuroscience in Psychiatry Training: How Much Do Residents Need To Know?Joshua L. Roffman, M.D.Asher B. Simon, M.D.Konasale M. Prasad, M.D.Christine J. Truman, M.D.Jason Morrison, M.D.Carrie L. Ernst, M.D.1 May 2006 | American Journal of Psychiatry, Vol. 163, No. 5Ending the Darkness of Suicide1 March 2006 | The Canadian Journal of Psychiatry, Vol. 51, No. 3Journal of Clinical Psychology, Vol. 62, No. 4Annals of Clinical Psychiatry, Vol. 18, No. 1International Clinical Psychopharmacology, Vol. 21, No. 6Journal of the American Psychoanalytic Association, Vol. 54, No. 4Manualized Supportive-Expressive Psychotherapy Versus Nonmanualized Community-Delivered Psychodynamic Therapy for Patients With Personality Disorders: Bridging Efficacy and EffectivenessBo Vinnars, M.A., Jacques P. Barber, Ph.D., Kristina Norén, M.A., Robert Gallop, Ph.D., and Robert M. Weinryb, M.D., Ph.D.1 October 2005 | American Journal of Psychiatry, Vol. 162, No. 10Recent Advances in the Treatment of Borderline Personality Disorder1 July 2005 | The Canadian Journal of Psychiatry, Vol. 50, No. 8Clinical Management for Hospital-Treated Deliberate Self-Poisoning: Comparisons between Patients with Major Depression and Borderline Personality Disorder26 June 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 39, No. 4International Journal of Clinical and Experimental Hypnosis, Vol. 53, No. 4International Journal of Psychiatry in Clinical Practice, Vol. 9, No. 3Psychopathology, Vol. 38, No. 2Psychiatry: Interpersonal and Biological Processes, Vol. 68, No. 2American Journal of Orthopsychiatry, Vol. 74, No. 1Eating Disorders, Vol. 13, No. 1Journal of Psychiatric Practice, Vol. 10, No. 3Journal of Psychiatric Practice, Vol. 10, No. 3Journal of Personality Disorders, Vol. 18, No. 1Journal of Personality Disorders, Vol. 18, No. 1Journal of Personality Disorders, Vol. 18, No. 3Journal of Personality Disorders, Vol. 18, No. 3Psychothérapies, Vol. 24, No. 2Psychotherapies and Older Adults17 November 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 37, No. 5Treatment Rejecting and Treatment Seeking Personality Disorders: Type R and Type SJournal of Personality Disorders, Vol. 17, No. 3Baseline personality functioning correlates with 6 month outcome in schizophrenia16 April 2020 | European Psychiatry, Vol. 18, No. 3Current Psychiatry Reports, Vol. 5, No. 3Scandinavian Journal of Caring Sciences, Vol. 17, No. 4American Journal of Clinical Hypnosis, Vol. 46, No. 1Current Opinion in Psychiatry, Vol. 16, No. 1Journal of Psychiatric Practice, Vol. 9, No. 4Journal of Psychiatric Practice, Vol. 9, No. 4Perspectives In Psychiatric Care, Vol. 39, No. 3Journal of Personality Disorders, Vol. 17, No. 6Psychiatry: Interpersonal and Biological Processes, Vol. 66, No. 3Revista de Psiquiatria do Rio Grande do Sul, Vol. 25, No. 2The World Journal of Biological Psychiatry, Vol. 4, No. 1The Borderline Personality Disorder Practice Guidelines: The Good, The Bad, and The RealisticJournal of Personality Disorders, Vol. 16, No. 2New Perspectives on the Psychotherapy of WomenPrimary Care: Clinics in Office Practice, Vol. 29, No. 1Professional Psychology: Research and Practice, Vol. 33, No. 1Psychoanalytic Psychology, Vol. 19, No. 4Journal of Personality Disorders, Vol. 16, No. 2Journal of Personality Disorders, Vol. 16, No. 2Journal of Personality Disorders, Vol. 16, No. 2The Fate of Integrated Treatment: Whatever Happened to the Biopsychosocial Psychiatrist?Glen O. Gabbard, M.D., and Jerald Kay, M.D.1 December 2001 | American Journal of Psychiatry, Vol. 158, No. 12Guilt From Negative Genetic Test FindingsYOSHIE MURAKAMI, R.N., M.S.N., NOBUHISA GONDO, M.D., HITOSHI OKAMURA, M.D., PH.D., TATSUO AKECHI, M.D., PH.D., and YOSUKE UCHITOMI, M.D., PH.D., 1 November 2001 | American Journal of Psychiatry, Vol. 158, No. 11Olanzapine Augmentation for TrichotillomaniaADAM KELLER ASHTON, M.D., 1 November 2001 | American Journal of Psychiatry, Vol. 158, No. 11"Mind" and "Brain"ROBERT M. GOSSART, M.D., 1 November 2001 | American Journal of Psychiatry, Vol. 158, No. 11Practical Psychotherapy: How Practice Guidelines Can Rescue Psychotherapy in Public SystemsRoderick Shaner, M.D.1 August 2001 | Psychiatric Services, Vol. 52, No. 8Economic Grand Rounds: Inpatient and Partial Hospital Care Under MedicareLloyd I. Sederer, M.D.1 August 2001 | Psychiatric Services, Vol. 52, No. 8Journal of Personality Disorders, Vol. 15, No. 6Psicologia: Teoria e Pesquisa, Vol. 17, No. 1 Volume 158Issue 1 January 2001Pages 1-3 Metrics PDF download History Published online 1 January 2001 Published in print 1 January 2001
Referência(s)